Although it's still a small portion of the $30-plus-billion diagnostic services and test supplies business, molecular diagnostics is on a disproportionately rapid growth curve. Some estimate its revenue growth at 25% a year compared to the overall industry average of 3-5%. Reimbursement is improving and robust new tests are emerging, slowly but steadily.
This growth can be looked at another way: in the US, the laboratory services market for these tests is currently more than $1.8 billion, with another $1 billion spent on...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?